冠心病合并心力衰竭患者冠状动脉支架术后临床效果的研究分析

目的:分析冠状动脉粥样硬化性心脏病(简称,冠心病)合并心力衰竭患者冠状动脉支架术后的临床效果。方法:选择2017年1月~2018年3月在本院就诊的72例冠心病合并心力衰竭患者作为本次的研究对象,术前3d给予患者肠溶阿司匹+氯吡格雷术前准备,手术时患者取半卧位,选择搏动良好的桡动脉行介入治疗,介入术后行经皮冠状动脉支架植入术,术后给予氯吡格雷+阿司匹林治疗。采用超声心动图监测,比较治疗前后的心功能相关指标。行6min步行试验,评估患者的运动耐力。依据纽约心脏病协会(NYHA)分级标准对患者治疗前后的心功能进行分级。结果:治疗后,患者各项心功能指标较治疗前比较,差异有统计学意义,P<0.05。治疗前,患者的平均6min步行距离为(165.3±48.8)m,治疗后,患者的平均6min步行距离为(232.6±69.4)m,较治疗前比较,差异有统计学意义,P<0.05。依据纽约心脏病协会(NYHA)分级标准:Ⅰ级25例(34.7%),Ⅱ级26例(36.1%),Ⅲ级21例(29.2%),Ⅳ级0例(0.0%),较治疗前比较,差异有统计学意义,P<0.05。结论:使用冠状动脉支架术治疗冠心病合并心力衰竭患者,能明显改善患者的心功能,疗效确切。

Clinical Analysis of Coronary Artery Disease Patients with Heart Failure After Coronary Stenting

Objective:To analyze the clinical effect of coronary artery disease in patients with coronary heart disease and heart failure.Methods:72 patients with coronary heart disease and heart failure who were treated in our hospital from January 2017 to March 2018 were selected as the study object.The patients were given enteric-coated aspirin+clopidogrel 3 days before surgery.During the operation,the patient was placed in a semi-recumbent position,and the radial artery with good pulsation was selected for interventional therapy.After the intervention,percutaneous coronary stent implantation was performed,and clopidogrel+aspirin was given after the operation.Echocardiographic monitoring was used to compare the relevant indexes of cardiac function before and after treatment.A 6-minute walk test was performed to evaluate the patient’s exercise endurance.The heart function of patients before and after treatment was graded according to the New York Heart Association(NYHA)classification standard.Results:After treatment,the patients’heart function indexes were compared with those before treatment,the difference was statistically significant,P<0.05.Before treatment,the patient’s average 6-minute walking distance was(165.3±48.8)m.After treatment,the patient’s average 6-minute walking distance was(232.6±69.4)m.Compared with before treatment,the difference was statistically significant,P<0.05.According to the New York Heart Association(NYHA)classification standard:25 cases(34.7%)of gradeⅠ,26 cases(36.1%)of gradeⅡ,21 cases(29.2%)of gradeⅢ,0 cases(0.0%)of gradeⅣ,compared with before treatment In comparison,the difference was statistically significant,P<0.05.Conclusion:The use of coronary stenting in the treatment of patients with coronary heart disease and heart failure can significantly improve the heart function of the patients,the curative effect is definite.